Protein kinase C-epsilon-null mice have decreased hypoxic pulmonary vasoconstriction

Am J Physiol Heart Circ Physiol. 2003 Apr;284(4):H1321-31. doi: 10.1152/ajpheart.00795.2002. Epub 2002 Dec 27.

Abstract

PKC contributes to regulation of pulmonary vascular reactivity in response to hypoxia. The role of individual PKC isozymes is less clear. We used a knockout (null, -/-) mouse to test the hypothesis that PKC-epsilon is important in acute hypoxic pulmonary vasoconstriction (HPV). We asked whether deletion of PKC-epsilon would decrease acute HPV in adult C57BL6xSV129 mice. In isolated, salt solution-perfused lung, reactivity to acute hypoxic challenges (0% and 3% O(2)) was compared with responses to angiotensin II (ANG II) and KCl. PKC-epsilon -/- mice had decreased HPV, whereas responses to ANG II and KCl were preserved. Inhibition of nitric oxide synthase (NOS) with nitro-l-arginine augmented HPV in PKC-epsilon +/+ but not -/- mice. Inhibition of Ca(2+)-gated K(+) channels (K(Ca)) with charybdotoxin and apamin did not enhance HPV in -/- mice relative to wild-type (+/+) controls. In contrast, the voltage-gated K(+) channel (K(V)) antagonist 4-aminopyridine increased the response of -/- mice beyond that of +/+ mice. This suggested that increased K(V) channel expression could contribute to blunted HPV in PKC-epsilon -/- mice. Therefore, expression of the O(2)-sensitive K(V) channel subunit Kv3.1b (100-kDa glycosylated form and 70-kDa core protein) was compared in whole lung and pulmonary artery smooth muscle cell (PASMC) lysates from +/+ and -/- mice. A subtle increase in Kv3.1b was detected in -/- vs. +/+ whole lung lysates. A much greater rise in Kv3.1b expression was found in -/- vs. +/+ PASMC. Thus deletion of PKC-epsilon blunts murine HPV. The decreased response could not be attributed to a general loss in vasoreactivity or derangements in NOS or K(Ca) channel activity. Instead, the absence of PKC-epsilon allows increased expression of K(V) channels (like Kv3.1b) to occur in PASMC, which likely contributes to decreased HPV.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Calcium / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Gene Deletion
  • Hypoxia / physiopathology*
  • Lung / blood supply*
  • Lung / chemistry
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Muscle, Smooth, Vascular / chemistry
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Oxygen / administration & dosage
  • Oxygen / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels / analysis
  • Potassium Channels / drug effects
  • Potassium Channels / physiology
  • Potassium Channels, Voltage-Gated*
  • Potassium Chloride / pharmacology
  • Protein Kinase C / deficiency*
  • Protein Kinase C / genetics
  • Protein Kinase C / physiology
  • Protein Kinase C-epsilon
  • Pulmonary Artery / chemistry
  • Pulmonary Artery / physiopathology
  • Shaw Potassium Channels
  • Vasoconstriction*

Substances

  • Enzyme Inhibitors
  • Kcnc1 protein, mouse
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Shaw Potassium Channels
  • Angiotensin II
  • Potassium Chloride
  • Nitric Oxide Synthase
  • Prkce protein, mouse
  • Protein Kinase C
  • Protein Kinase C-epsilon
  • Oxygen
  • Calcium